Extending the period of initial cardiopulmonary resuscitation (CPR) by paramedics and firefighters from one to three minutes provides no benefit, according to what is touted as the largest randomized cardiac arrest trial in the world.
Although treatment with two angiotensin medications—an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II receptor blocker (ARB)—is controversial, a new study suggests that the combination may benefit patients with atrial fibrillation.
Individuals who see the with anger and have a history of heart disease are more likely than their more mellow counterparts to experience a recurrent myocardial infarction, researchers reported here.